#Dr Reddy’s Laboratories
Health
Dr Reddy’s, Takeda to Distribute QDENGA Dengue Vaccine in India
Dr Reddy’s and Takeda have signed an agreement to distribute QDENGA in India’s private market, with availability expected in the first half of 2027.
Health
Dr Reddy’s Launches Nivorz in India’s Biosimilar Market
Dr Reddy’s enters India’s biosimilar immuno-oncology market with Nivorz, a biosimilar of nivolumab, developed and manufactured at its Hyderabad facility.